Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 65

Results For "Meta"

755 News Found

Innovative therapy that ‘tricks’ and destroys cancer cells advance to clinical trial
Biotech | April 10, 2022

Innovative therapy that ‘tricks’ and destroys cancer cells advance to clinical trial

Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer


BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022
News | April 07, 2022

BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022

Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)


Good microbiome and probiotics key to good health
Healthcare | April 04, 2022

Good microbiome and probiotics key to good health

The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram


Researchers discover new model for
Biotech | March 31, 2022

Researchers discover new model for "Global" DNA repair

A major unresolved question in the field, however, is how do this machinery rapidly searches for and finds rare stretches of damage amid the "vast fields" of undamaged DNA


TDB approves funding for MIM in MedTech
News | March 30, 2022

TDB approves funding for MIM in MedTech

Technology Development Board supports commercialisation of Metal Injection Molding of implants


ASC Therapeutics gets green light to advance gene therapy for Hemophilia A
Biotech | March 30, 2022

ASC Therapeutics gets green light to advance gene therapy for Hemophilia A

A novel second-generation approach to achieve a safe, durable, and stable transgene expression to overcome the challenges of factor VIII replacement therapies


NMPA approves Hansizhuang, its first monoclonal antibody
Drug Approval | March 27, 2022

NMPA approves Hansizhuang, its first monoclonal antibody

It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry


Bar Ilan University launches course on 3D printing in medicine
News | March 25, 2022

Bar Ilan University launches course on 3D printing in medicine

A new course at the Azrieli Faculty of Medicine will focus on tissue regeneration and 3D printing for therapeutic needs


USFDA approves Novartis Pluvicto to treat prostrate cancer
Drug Approval | March 24, 2022

USFDA approves Novartis Pluvicto to treat prostrate cancer

USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions